- Trials with a EudraCT protocol (218)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
218 result(s) found for: Hypertrophy.
Displaying page 1 of 11.
EudraCT Number: 2008-008479-32 | Sponsor Protocol Number: SR001 | Start Date*: 2009-06-09 | |||||||||||||||||||||
Sponsor Name:University of Dundee | |||||||||||||||||||||||
Full Title: Do xanthine oxidase inhibitors reduce left ventricular hypertrophy and endothelial dysfunction in normotensive patients with chronic stable angina? | |||||||||||||||||||||||
Medical condition: Left ventricular hypertrophy Normotensive Chronic stable angina | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-008485-12 | Sponsor Protocol Number: eb/lm/let390/ln950/20038 | Start Date*: 2009-07-01 | ||||||||||||||||
Sponsor Name:University of Dundee | ||||||||||||||||||
Full Title: Do Xanthine Oxidase Inhibitors Regress Left ventricular Hypertrophy in Diabetes? | ||||||||||||||||||
Medical condition: Diabetes Left Ventricular Hypertrophy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-005320-10 | Sponsor Protocol Number: Olivier-Faivre-SIROLIMUS-2014 | Start Date*: 2016-02-25 | |||||||||||
Sponsor Name:CHU de DIJON | |||||||||||||
Full Title: Non-randomised Open Label Pilot Study of Sirolimus Therapy for Segmental Overgrowth Due to PIK3CA- Related Overgrowth | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002198-37 | Sponsor Protocol Number: ENHVIE | Start Date*: 2016-09-19 | |||||||||||
Sponsor Name:HOSPITAL UNIVERSITARI DE BELLVITGE - IDIBELL | |||||||||||||
Full Title: A single-center, randomized, open-label, 12 months study, with two parallel group to compare the efficacy of everolimus combination + tacrolimus in regression of left ventricular hypertrophy vs tac... | |||||||||||||
Medical condition: Left ventricular hypertrophy in renal transplant patients in the maintenance phase . | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001977-17 | Sponsor Protocol Number: CVAA489ADE02 | Start Date*: 2006-10-17 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: An open-label, randomized, parallel group study comparing the efficacy and safety of Amlodipine in combination with Valsartan compared to Losartan in combination with Hydrochlorothiazide given for ... | |||||||||||||
Medical condition: patients with mild-to-moderate hypertension and left ventricular hypertrophy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002083-33 | Sponsor Protocol Number: 2012CV15 | Start Date*: 2014-07-22 | ||||||||||||||||
Sponsor Name:University of Dundee/NHS Tayside | ||||||||||||||||||
Full Title: Does Allopurinol regress Left Ventricular Hypertrophy in Patients with Treated Essential Hypertension? | ||||||||||||||||||
Medical condition: Left ventricular hypertrophy in hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004760-49 | Sponsor Protocol Number: MK001 | Start Date*: 2008-01-02 | ||||||||||||||||
Sponsor Name:University of Dundee | ||||||||||||||||||
Full Title: Do Xanthine Oxidase Inhibitors reduce both Left Ventricular Hypertrophy and Vascular Dysfunction in Cardiovascular patients with Renal Dysfunction? | ||||||||||||||||||
Medical condition: Chronic Kidney Disease Stage 3 Left Ventricular Hypertrophy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-003532-30 | Sponsor Protocol Number: BCSK/05/Pro-BPH/001 | Start Date*: 2006-12-29 | |||||||||||
Sponsor Name:Berlin-Chemie AG (Menarini Group) | |||||||||||||
Full Title: Efficacy of two formulations of Sabal serrulata; a double-blind; randomized; placebo-controlled phase III study | |||||||||||||
Medical condition: Benign prostate hyperplasia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: LT (Completed) DE (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000077-39 | Sponsor Protocol Number: RECOGITO_V1.0_2014 | Start Date*: 2014-02-27 | |||||||||||||||||||||
Sponsor Name:Sapienza University of Rome | |||||||||||||||||||||||
Full Title: Study on New Insights in Remodeling of Diabetic Cardiomyopathy: Gender Difference in Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phospho... | |||||||||||||||||||||||
Medical condition: Diabetic Cardiomyopathy, Diabetes Mellitus Type 2, Left Ventricular Hypertrophy | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004923-40 | Sponsor Protocol Number: P04367 | Start Date*: 2015-04-03 |
Sponsor Name:Schering-Plough Levant | ||
Full Title: Double blind, placebo controlled trial, evaluating the role of Nasonex® in the management of nasal obstruction secondary to adenoids hypertrophy in children. | ||
Medical condition: adenoids | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2007-003578-24 | Sponsor Protocol Number: FE 200486 CS25 | Start Date*: 2008-06-30 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A single-centre, open-label, randomised explorative pharmacokinetic/pharmacodynamic study of the gonadotropin-releasing hormone receptor antagonist degarelix (FE 200486) in patients with benign pro... | |||||||||||||
Medical condition: Patients with Benign Prostata Hypertropia (BPH) who fulfil the following criteria: a prostate volume of more than 30 mL, maximal uroflow of 12 mL/s or less; International Prostate Symptom Score (IP... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003189-26 | Sponsor Protocol Number: Version1.2 | Start Date*: 2014-12-01 | |||||||||||||||||||||
Sponsor Name:University of Dundee/NHS Tayside | |||||||||||||||||||||||
Full Title: Metformin and its Effects on Myocardial Dimension and Left ventricular hypertrophy in normotensive patients with Coronary Artery Disease. | |||||||||||||||||||||||
Medical condition: Cardiovascular disease | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004724-21 | Sponsor Protocol Number: 3963 | Start Date*: 2007-12-21 | ||||||||||||||||
Sponsor Name:Hôpitaux Universitaires de Strasbourg | ||||||||||||||||||
Full Title: INTERET DES STATINES DANS LE RETRECISSEMENT AORTIQUE CHIRURGICAL : DU PRECONDITIONNEMENT MYOCARDIAQUE A L’INVERSION DU REMODELAGE VENTRICULAIRE | ||||||||||||||||||
Medical condition: Valvulopathie aortique - hypertrophie ventriculaire gauche | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000222-38 | Sponsor Protocol Number: P00048GP404 | Start Date*: 2014-06-03 | |||||||||||
Sponsor Name:PIERRE FABRE MEDICAMENT | |||||||||||||
Full Title: PERMIXON® 160 mg hard capsule versus placebo in the treatment of symptomatic lower urinary tract symptoms due to benign prostatic hyperplasia. Single-blind placebo run-in period then double-blin... | |||||||||||||
Medical condition: PERMIXON® 160 mg hard capsule versus placebo in the treatment of symptomatic lower urinary tract symptoms due to benign prostatic hyperplasia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) ES (Completed) CZ (Completed) DE (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012325-11 | Sponsor Protocol Number: FE 200486 CS36 | Start Date*: 2009-10-21 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A dose-finding, multi-centre, double-blind, randomised, parallel, placebo-controlled trial to investigate efficacy and safety of degarelix in men with lower urinary tract symptoms (LUTS) associated... | |||||||||||||
Medical condition: Bening Prostate Hyperplasia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: CZ (Completed) GB (Completed) DK (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005092-33 | Sponsor Protocol Number: M10-221 | Start Date*: 2008-06-10 | ||||||||||||||||
Sponsor Name:Abbott GmbH & Co. KG | ||||||||||||||||||
Full Title: The PRIMO II Study: Paricalcitol Injection benefits in Renal failure Induced cardiac Morbidity in Subjects with Chronic Kidney Disease Stage 5 | ||||||||||||||||||
Medical condition: Stage 5 Chronic Kidney Disease (CKD) in subjects receiving hemodialysis who have left ventricular hypertrophy (LVH). | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) ES (Completed) GB (Prematurely Ended) CZ (Completed) GR (Prematurely Ended) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-001689-34 | Sponsor Protocol Number: M10-030 | Start Date*: 2008-04-24 | ||||||||||||||||
Sponsor Name:Abbott GmbH & Co. KG | ||||||||||||||||||
Full Title: The PRIMO Study: Paricalcitol Capsules benefits in Renal failure Induced cardiac Morbidity in Subjects with Chronic Kidney Disease Stage 3B/4. Estudio Primo: Beneficios de Paricalcitol cápsulas sob... | ||||||||||||||||||
Medical condition: Stage 3B/4 chronic kidney disease (CKD) in subjects who have left ventricular hypertrophy (LVH). Insuficiencia renal crónica en estadío 3B/4 en sujetos con hipertrofia ventricular izquierda. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) CZ (Completed) GB (Completed) IT (Completed) DE (Completed) SE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-005307-33 | Sponsor Protocol Number: P00048GP403 | Start Date*: 2012-09-24 | |||||||||||
Sponsor Name:PIERRE FABRE MEDICAMENT | |||||||||||||
Full Title: Exploratory study of L.S.E.S.r. (PERMIXON® 160 mg hard capsule) versus Tamsulosine LP activity on inflammation biomarkers in the treatment of urinary symptoms related to BPH, A multinational, multi... | |||||||||||||
Medical condition: The aim of the proposed study is to assess the activity on inflammation biomarkers of L.S.E.S.r (PERMIXON® 160mg hard capsule) and Tamsulosine LP in the treatment of BPH. The potential links betwee... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Completed) ES (Completed) IT (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003494-26 | Sponsor Protocol Number: Florence-PROTEST | Start Date*: 2012-10-26 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI | |||||||||||||
Full Title: EVALUATION OF THE EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON PROSTATIC INFLAMMATION AND LOWER URINARY TRACT SYMPTOMS IN HYPOGONADAL SUBJECTS | |||||||||||||
Medical condition: metabolic syndrome and BPH patients who will undergo simple prostatectomy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002376-95 | Sponsor Protocol Number: RRK3535 | Start Date*: 2009-01-05 |
Sponsor Name:University Hospital Birmingham NHS Foundation Trust | ||
Full Title: Myocardial protection with Perhexiline in Left Ventricular Hypertrophy | ||
Medical condition: Patients with left ventricular hypertrophy undergoing aortic valve surgery (with or without coronary artery surgery) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.